Is the risk of neoplastic recurrence increased after prescribing direct-acting antivirals for HCV patients whose HCC was previously cured?
Is the risk of neoplastic recurrence increased after prescribing direct-acting antivirals for HCV patients whose HCC was previously cured?
复制标题
DOI：
10.1016/j.jhep.2016.08.016
复制
发表时间：
2017
影响因子：
25.7
通讯作者：
C. Zavaglia;S. Okolicsanyi;L. Cesarini;C. Mazzarelli;V. Pontecorvi;A. Ciaccio;M. Strazzabosco;L. Belli
中科院分区：
文献类型：
--
作者：
C. Zavaglia;S. Okolicsanyi;L. Cesarini;C. Mazzarelli;V. Pontecorvi;A. Ciaccio;M. Strazzabosco;L. Belli
